Boothbay Fund Management, LLC Vascular Biogenics Ltd. Transaction History

Boothbay Fund Management, LLC

  • $3.37 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$1.94 - $2.55 $19,347 - $25,431
-9,973 Reduced 11.12%
79,716 $163,000
Q1 2021

May 17, 2021
BUY
$1.79 - $2.91 $160,543 - $260,994
89,689 New
89,689 $179,000
Q2 2018

Aug 14, 2018
SELL
$2.05 - $3.0 $23,089 - $33,789
-11,263 Closed
0 $0
Q1 2018

May 14, 2018
BUY
$2.27 - $8.5 $25,567 - $95,735
11,263 New
11,263 $26,000

Others Institutions Holding VBLT

# of Institutions
2
Shares Held
416K
Call Options Held
0
Put Options Held
0
View Full List

About Vascular Biogenics Ltd.

VBLT Quotes by TradingView
  • Ticker VBLT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,348,896
  • Description
  • Vascular Biogenics Ltd., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of cancer and immune-inflammatory diseases in Israel and the United States. Its programs are based on its vascular targeting system, a gene-based technology targeting newly formed blood vessels; and monocyte targeting technology, an antib...
More about VBLT
Track This Portfolio

Track Boothbay Fund Management, LLC Portfolio

Follow Boothbay Fund Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boothbay Fund Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email